Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Sheon

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
JAMA|August 9, 1971
Systemic lupus erythematosus with cutaneous ulceration. Correlation of immunologic factors with therapy and clinical activityA B Kirsner, J G Diller, R P Sheon
Postgraduate Medicine|June 1, 1982
The hypermobility syndromeR P Sheon, A B Kirsner, S J Farber, et al.
Annals of the Rheumatic Diseases|January 1, 1982
The incidence of malignant disease in patients receiving cytotoxic therapy for rheumatoid arthritisA B Kirsner, S J Farber, R P Sheon, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1975
Cell-mediated immunity in systemic lupus erythematosus: alterations with advancing ageB S Foad, S Khullar, E H Freimer, et al.
Journal of the American Geriatrics Society|January 1, 1977
Malignancy in rheumatic disease: interrelationshipsR P Sheon, A B Kirsner, P Tangsintanapas, et al.
Arthritis and Rheumatism|May 1, 1990
Early-onset primary osteoarthritis and mild chondrodysplasia. Radiographic and pathologic studies with an analysis of cartilage proteoglycansP L Katzenstein, C J Malemud, M N Pathria, et al.
The Journal of Rheumatology. Supplement|July 1, 1982
The efficacy and safety of auranofin compared to placebo in rheumatoid arthritisW A Katz, S Alexander, J H Bland, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
JAMA|August 9, 1971
Systemic lupus erythematosus with cutaneous ulceration. Correlation of immunologic factors with therapy and clinical activityA B Kirsner, J G Diller, R P Sheon
Postgraduate Medicine|June 1, 1982
The hypermobility syndromeR P Sheon, A B Kirsner, S J Farber, et al.
Annals of the Rheumatic Diseases|January 1, 1982
The incidence of malignant disease in patients receiving cytotoxic therapy for rheumatoid arthritisA B Kirsner, S J Farber, R P Sheon, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1975
Cell-mediated immunity in systemic lupus erythematosus: alterations with advancing ageB S Foad, S Khullar, E H Freimer, et al.
Journal of the American Geriatrics Society|January 1, 1977
Malignancy in rheumatic disease: interrelationshipsR P Sheon, A B Kirsner, P Tangsintanapas, et al.
Arthritis and Rheumatism|May 1, 1990
Early-onset primary osteoarthritis and mild chondrodysplasia. Radiographic and pathologic studies with an analysis of cartilage proteoglycansP L Katzenstein, C J Malemud, M N Pathria, et al.
The Journal of Rheumatology. Supplement|July 1, 1982
The efficacy and safety of auranofin compared to placebo in rheumatoid arthritisW A Katz, S Alexander, J H Bland, et al.
Pageof 3